CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $324.00 ($485,993)
- 4 Gift Director gave 80,000 shares (gift)
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $320.73 ($481,099)
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $322.99 ($484,492)
- 4 Open-market sale CFO & Chief Strategy Officer sold 14,000 shares at an average $344.85 ($4,827,945)
- 4 Open-market sale Director sold 121,154 shares at $220.50 ($26,714,457)
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $249.13 ($373,690)
- 4 Grant or award 10% owner acquired 25,762 shares (grant or award)
- 4 Grant or award 10% owner acquired 228,138 shares (grant or award)
- 4 Gift Director gave 165,295 shares (gift)
- 4 Open-market sale CFO & Chief Strategy Officer sold 91,900 shares at an average $229.04 ($21,048,454)
- 4 Gift Chief Executive Officer gave 2,136,914 shares (gift)
- 4 Gift Director gave 1,332,552 shares (gift)
- 4 Gift Director gave 589,849 shares (gift)
- 4 Open-market sale Director sold 1,511,546 shares at $220.50 ($333,295,893)
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $267.82 ($401,723)
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $300.06 ($450,093)
- 4 Open-market sale Director sold 5,000 shares at $320.00 ($1,600,000)
- 4 Open-market sale Director sold 5,000 shares at $300.00 ($1,500,000)
Page 17 of 29 · 580 filings